These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36396039)

  • 1. Analytical approaches to evaluating hypertensive disorders of pregnancy.
    Knupp RJ; Subramaniam A; Tita ANT; Sinkey R; Battarbee AN
    Am J Obstet Gynecol MFM; 2023 Feb; 5(2):100816. PubMed ID: 36396039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia between 34 and 37 weeks' gestation (HYPITAT-II): a multicentre, open-label randomised controlled trial.
    Langenveld J; Broekhuijsen K; van Baaren GJ; van Pampus MG; van Kaam AH; Groen H; Porath M; Oudijk MA; Bloemenkamp KW; Groot CJ; van Beek E; van Huizen ME; Oosterbaan HP; Willekes C; Wijnen-Duvekot EJ; Franssen MT; Perquin DA; Sporken JM; Woiski MD; Bremer HA; Papatsonis DN; Brons JT; Kaplan M; Nij Bijvanck BW; Mol BW;
    BMC Pregnancy Childbirth; 2011 Jul; 11():50. PubMed ID: 21736705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A risk of waiting: the weekly incidence of hypertensive disorders and associated maternal and neonatal morbidity in low-risk term pregnancies.
    Gibson KS; Waters TP; Bailit JL
    Am J Obstet Gynecol; 2016 Mar; 214(3):389.e1-389.e12. PubMed ID: 26440691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is gestational age at term a risk factor for ongoing pregnancies in nulliparous women: A prospective cohort study.
    Quibel T; Rozenberg P; Duvillier C; Bouyer C; Bouyer J
    Am J Obstet Gynecol MFM; 2023 Feb; 5(2):100808. PubMed ID: 36371036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neonatal developmental and behavioral outcomes of immediate delivery versus expectant monitoring in mild hypertensive disorders of pregnancy: 2-year outcomes of the HYPITAT-II trial.
    Zwertbroek EF; Franssen MTM; Broekhuijsen K; Langenveld J; Bremer H; Ganzevoort W; van Loon AJ; van Pampus MG; Rijnders RJP; Sikkema MJ; Scherjon SA; Woiski MD; Mol BWJ; van Baar AL; Groen H;
    Am J Obstet Gynecol; 2019 Aug; 221(2):154.e1-154.e11. PubMed ID: 30940558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal and neonatal outcomes of elective induction of labor.
    Caughey AB; Sundaram V; Kaimal AJ; Cheng YW; Gienger A; Little SE; Lee JF; Wong L; Shaffer BL; Tran SH; Padula A; McDonald KM; Long EF; Owens DK; Bravata DM
    Evid Rep Technol Assess (Full Rep); 2009 Mar; (176):1-257. PubMed ID: 19408970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the maternal and perinatal sequelae of severe gestational hypertension.
    Kumar NR; Grobman WA; Barry O; Clement AC; Lancki N; Yee LM
    Am J Obstet Gynecol MFM; 2021 Jan; 3(1):100280. PubMed ID: 33451611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fetal growth patterns in pregnancy-associated hypertensive disorders: NICHD Fetal Growth Studies.
    Mateus J; Newman RB; Zhang C; Pugh SJ; Grewal J; Kim S; Grobman WA; Owen J; Sciscione AC; Wapner RJ; Skupski D; Chien E; Wing DA; Ranzini AC; Nageotte MP; Gerlanc N; Albert PS; Grantz KL
    Am J Obstet Gynecol; 2019 Dec; 221(6):635.e1-635.e16. PubMed ID: 31226296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal and neonatal characteristics associated with neonatal neutropenia in hypertensive pregnancies.
    Sharma G; Nesin M; Feuerstein M; Bussel JB
    Am J Perinatol; 2009 Oct; 26(9):683-9. PubMed ID: 19670129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium intake and the development of hypertensive disorders of pregnancy.
    Bank TC; Grasch JL; Chung J; Mercer BM; McNeil RB; Parry S; Saade G; Shanks A; Silver RM; Simhan H; Yee LM; Reddy U; Grobman WA; Frey HA
    Am J Obstet Gynecol MFM; 2023 Nov; 5(11):101166. PubMed ID: 37741626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trial.
    Koopmans CM; Bijlenga D; Groen H; Vijgen SM; Aarnoudse JG; Bekedam DJ; van den Berg PP; de Boer K; Burggraaff JM; Bloemenkamp KW; Drogtrop AP; Franx A; de Groot CJ; Huisjes AJ; Kwee A; van Loon AJ; Lub A; Papatsonis DN; van der Post JA; Roumen FJ; Scheepers HC; Willekes C; Mol BW; van Pampus MG;
    Lancet; 2009 Sep; 374(9694):979-988. PubMed ID: 19656558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivery or expectant management for prevention of adverse maternal and neonatal outcomes in hypertensive disorders of pregnancy: an individual participant data meta-analysis.
    Bernardes TP; Zwertbroek EF; Broekhuijsen K; Koopmans C; Boers K; Owens M; Thornton J; van Pampus MG; Scherjon SA; Wallace K; Langenveld J; van den Berg PP; Franssen MTM; Mol BWJ; Groen H
    Ultrasound Obstet Gynecol; 2019 Apr; 53(4):443-453. PubMed ID: 30697855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic hypertension diagnosed by the American Heart Association and American College of Cardiology criteria is associated with increased risk of developing hypertensive disorders of pregnancy.
    Advani R; Chandrasekaran S
    Am J Obstet Gynecol MFM; 2024 Mar; 6(3):101269. PubMed ID: 38145820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perinatal outcomes in women with elevated blood pressure and stage 1 hypertension.
    Greenberg VR; Silasi M; Lundsberg LS; Culhane JF; Reddy UM; Partridge C; Lipkind HS
    Am J Obstet Gynecol; 2021 May; 224(5):521.e1-521.e11. PubMed ID: 33157064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between insurance type and pregnancy outcomes in women diagnosed with hypertensive disorders of pregnancy.
    Greiner KS; Speranza RJ; Rincón M; Beeraka SS; Burwick RM
    J Matern Fetal Neonatal Med; 2020 Apr; 33(8):1427-1433. PubMed ID: 30182768
    [No Abstract]   [Full Text] [Related]  

  • 16. Differences in disease severity and delivery gestational age between black and white patients with hypertensive disorders of pregnancy.
    Teal EN; Appiagyei A; Sheffield-Abdullah K; Manuck TA
    Pregnancy Hypertens; 2022 Jun; 28():88-93. PubMed ID: 35290940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACC-AHA Diagnostic Criteria for Hypertension in Pregnancy Identifies Patients at Intermediate Risk of Adverse Outcomes.
    Darwin KC; Federspiel JJ; Schuh BL; Baschat AA; Vaught AJ
    Am J Perinatol; 2021 Aug; 38(S 01):e249-e255. PubMed ID: 32446257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The optimal gestational age to deliver patients with chronic hypertension on antihypertensive therapy.
    Jeganathan S; Blitz MJ; Makol AK; Juhel HS; Joseph A; Hentz R; Rochelson B; Rafael TJ
    J Matern Fetal Neonatal Med; 2023 Dec; 36(1):2210727. PubMed ID: 37150597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood pressure trajectory and category and risk of hypertensive disorders of pregnancy in nulliparous women.
    Hauspurg A; Parry S; Mercer BM; Grobman W; Hatfield T; Silver RM; Parker CB; Haas DM; Iams JD; Saade GR; Wapner RJ; Reddy UM; Simhan H
    Am J Obstet Gynecol; 2019 Sep; 221(3):277.e1-277.e8. PubMed ID: 31255629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of extended postpartum inpatient monitoring for hypertensive disorders of pregnancy to reduce the risk of readmission for preeclampsia with severe features.
    Bronner BA; Trowbridge PL; Perry AC; McCormick AC; Waters TP; de Los Reyes S
    Am J Obstet Gynecol MFM; 2023 Jul; 5(7):100956. PubMed ID: 37023986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.